
Carisma Therapeutics to Highlight Breakthroughs in Cancer Immunotherapy at AACR Annual Meeting
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM), a pioneering force in the development of innovative cancer immunotherapies, has announced its participation in the upcoming American Association for Cancer Research …
Carisma Therapeutics to Highlight Breakthroughs in Cancer Immunotherapy at AACR Annual Meeting Read More